1. Home
  2. ZURA vs AUID Comparison

ZURA vs AUID Comparison

Compare ZURA & AUID Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ZURA
  • AUID
  • Stock Information
  • Founded
  • ZURA 2022
  • AUID 2009
  • Country
  • ZURA United States
  • AUID United States
  • Employees
  • ZURA N/A
  • AUID N/A
  • Industry
  • ZURA Biotechnology: Biological Products (No Diagnostic Substances)
  • AUID Computer Software: Prepackaged Software
  • Sector
  • ZURA Health Care
  • AUID Technology
  • Exchange
  • ZURA Nasdaq
  • AUID Nasdaq
  • Market Cap
  • ZURA 61.9M
  • AUID 72.6M
  • IPO Year
  • ZURA N/A
  • AUID N/A
  • Fundamental
  • Price
  • ZURA $1.13
  • AUID $4.94
  • Analyst Decision
  • ZURA Buy
  • AUID
  • Analyst Count
  • ZURA 7
  • AUID 0
  • Target Price
  • ZURA $14.33
  • AUID N/A
  • AVG Volume (30 Days)
  • ZURA 545.9K
  • AUID 111.4K
  • Earning Date
  • ZURA 08-08-2025
  • AUID 08-07-2025
  • Dividend Yield
  • ZURA N/A
  • AUID N/A
  • EPS Growth
  • ZURA N/A
  • AUID N/A
  • EPS
  • ZURA N/A
  • AUID N/A
  • Revenue
  • ZURA N/A
  • AUID $1,025,363.00
  • Revenue This Year
  • ZURA N/A
  • AUID N/A
  • Revenue Next Year
  • ZURA N/A
  • AUID N/A
  • P/E Ratio
  • ZURA N/A
  • AUID N/A
  • Revenue Growth
  • ZURA N/A
  • AUID 230.96
  • 52 Week Low
  • ZURA $0.97
  • AUID $4.01
  • 52 Week High
  • ZURA $5.07
  • AUID $10.95
  • Technical
  • Relative Strength Index (RSI)
  • ZURA 45.37
  • AUID 46.49
  • Support Level
  • ZURA $1.10
  • AUID $4.16
  • Resistance Level
  • ZURA $1.37
  • AUID $5.03
  • Average True Range (ATR)
  • ZURA 0.09
  • AUID 0.44
  • MACD
  • ZURA 0.00
  • AUID 0.02
  • Stochastic Oscillator
  • ZURA 37.18
  • AUID 61.94

About ZURA Zura Bio Limited

Zura Bio Ltd is a clinical-stage, multi-asset immunology company developing novel dual-pathway antibodies for autoimmune and inflammatory diseases. It is developing three assets which have completed Phase I/Ib studies and are Phase II ready. It is developing a portfolio of therapeutic indications for tibulizumab and torudokimab with a goal of demonstrating their efficacy, safety, and dosing convenience in autoimmune and inflammatory diseases.

About AUID authID Inc.

AuthID Inc is a company engaged in ensuring cyber-savvy enterprises Know Who's Behind the Device, for every customer or employee login and transaction. Through its easy-to-integrate, patented, biometric identity platform, authID quickly and accurately verifies a user's identity, eliminating any assumption of who is behind a device and preventing cybercriminals from taking over accounts. authID combines digital onboarding, biometric password less authentication and account recovery, with a fast, accurate, user-friendly experience-delivering identity verification.

Share on Social Networks: